Biocon Limited receives the final inspection report from EDQM

NOTIFICATION TO STOCK EXCHANGE

COMPANY STATEMENT

Bengaluru, Karnataka, India, Dec 22, 2022

“This is to inform you that Biocon Limited has been issued a Good Manufacturing Practice (GMP) Certificate of Compliance by the European Directorate for the Quality of Medicines & HealthCare (EDQM), for our Active Pharmaceutical Ingredient (API) manufacturing facility in Bangalore. This certification is based on a GMP inspection of the site that was conducted between the 12^th and 14^th of September 2022.”